399 related articles for article (PubMed ID: 26572612)
1. Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare.
Portincasa P
Curr Med Chem; 2016; 23(1):60-86. PubMed ID: 26572612
[TBL] [Abstract][Full Text] [Related]
2. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
Portincasa P; Scaccianoce G; Palasciano G
Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
[TBL] [Abstract][Full Text] [Related]
3. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
Sozeri B; Kasapcopur O
Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
[TBL] [Abstract][Full Text] [Related]
4. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
Gül A
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
[TBL] [Abstract][Full Text] [Related]
5. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
[TBL] [Abstract][Full Text] [Related]
6. Familial Mediterranean fever, review of the literature.
Alghamdi M
Clin Rheumatol; 2017 Aug; 36(8):1707-1713. PubMed ID: 28624931
[TBL] [Abstract][Full Text] [Related]
7. [Familial Mediterranean fever – an important disease in a globalised world].
Wekell P; Karlsson A; Fasth A; Berg S
Lakartidningen; 2016 Aug; 113():. PubMed ID: 27551868
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approach to familial Mediterranean fever: a review update.
Ozturk MA; Kanbay M; Kasapoglu B; Onat AM; Guz G; Furst DE; Ben-Chetrit E
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S77-86. PubMed ID: 21968242
[TBL] [Abstract][Full Text] [Related]
9. Familial Mediterranean fever in childhood: a single-center experience.
Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
[TBL] [Abstract][Full Text] [Related]
10. [Familial Mediterranean fever].
Georgin-Lavialle S; Hentgen V; Stankovic Stojanovic K; Bachmeyer C; Rodrigues F; Savey L; Abbara S; Conan PL; Fraisse T; Delplanque M; Rouet A; Sbeih N; Koné-Paut I; Grateau G
Rev Med Interne; 2018 Apr; 39(4):240-255. PubMed ID: 29526329
[TBL] [Abstract][Full Text] [Related]
11. Biologic therapy in familial Mediterranean fever.
Koga T; Migita K; Kawakami A
Mod Rheumatol; 2016 Sep; 26(5):637-41. PubMed ID: 26939747
[TBL] [Abstract][Full Text] [Related]
12. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous necrotizing vasculitis as a manifestation of familial Mediterranean fever.
Komatsu S; Honma M; Igawa S; Tsuji H; Ishida-Yamamoto A; Migita K; Ida H; Iizuka H
J Dermatol; 2014 Sep; 41(9):827-9. PubMed ID: 25109905
[TBL] [Abstract][Full Text] [Related]
15. Canakinumab for the treatment of familial Mediterranean fever.
Ozdogan H; Ugurlu S
Expert Rev Clin Immunol; 2017 May; 13(5):393-404. PubMed ID: 28362189
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
Erten S; Erten SF; Altunoglu A
Rheumatol Int; 2012 Apr; 32(4):1095-7. PubMed ID: 21431291
[TBL] [Abstract][Full Text] [Related]
17. An overview of familial Mediterranean fever with emphasis on pyrin and colchicine.
Dbouk HA; Uthman IW
J Med Liban; 2008; 56(1):35-41. PubMed ID: 19534089
[TBL] [Abstract][Full Text] [Related]
18. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
[TBL] [Abstract][Full Text] [Related]
19. [Familial Mediterranean fever: not to be missed].
Frenkel J; Bemelman FJ; Potter van Loon BJ; Simon A
Ned Tijdschr Geneeskd; 2013; 157(18):A5784. PubMed ID: 23635502
[TBL] [Abstract][Full Text] [Related]
20. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
Ozkan S; Atas B
J Pak Med Assoc; 2017 Jun; 67(6):945-947. PubMed ID: 28585601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]